Zydus Lifesciences Announces 2026 Buyback Record Date with Acceptance Ratio and Revised Profit Guidance.
SKIP_POST
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)
SKIP_POST
Source: The Economic Times
(Expert Note: This report was prepared by the Wealthova IPO team.)